Abstract
Controversy in medicine is inevitable, but it becomes problematic when the issue is a serious public health problem requiring a clear plan of action. In recent years measles has made a major resurgence in this country, with provisional figures showing 89 measles-related deaths in 1990. The Immunization Practices Advisory Committee of the US Public Health Service, the Committee on Infectious Diseases of the American Academy of Pediatrics, and the US Preventive Services Task Force have all issued recommendations for measles immunization. Most of these recommendations are in agreement, but they conflict on the age at which vaccination should be given and the number of doses. To assist physicians in disentangling this complex web, I review the history of measles immunization in the United States and give the rationale for particular positions wherein the groups disagree. I describe protocols for routine vaccinations, endemic areas, outbreak control, colleges and universities, and international travel.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Addiss D. G., Berg J. L., Davis J. P. Revaccination of previously vaccinated siblings of children with measles during an outbreak. J Infect Dis. 1988 Mar;157(3):610–611. doi: 10.1093/infdis/157.3.610. [DOI] [PubMed] [Google Scholar]
- BERKOVICH S., STARR S. Use of live-measles-virus vaccine to abort an expected outbreak of measles within a closed population. N Engl J Med. 1963 Jul 11;269:75–77. doi: 10.1056/NEJM196307112690204. [DOI] [PubMed] [Google Scholar]
- FULGINITI V. A., KEMPE C. H. MEASLES EXPOSURE AMONG VACCINE RECIPIENTS. RESPONSE TO MEASLES EXPOSURE AND ANTIBODY PERSISTENCE AMONG RECIPIENTS OF MEASLES VACCINES. Am J Dis Child. 1963 Nov;106:450–461. doi: 10.1001/archpedi.1963.02080050452010. [DOI] [PubMed] [Google Scholar]
- Hersh B. S., Fine P. E., Kent W. K., Cochi S. L., Kahn L. H., Zell E. R., Hays P. L., Wood C. L. Mumps outbreak in a highly vaccinated population. J Pediatr. 1991 Aug;119(2):187–193. doi: 10.1016/s0022-3476(05)80726-7. [DOI] [PubMed] [Google Scholar]
- Hersh B. S., Markowitz L. E., Maes E. F., Funkhouser A. W., Baughman A. L., Sirotkin B. I., Hadler S. C. The geographic distribution of measles in the United States, 1980 through 1989. JAMA. 1992 Apr 8;267(14):1936–1941. [PubMed] [Google Scholar]
- Krugman S. Further-attenuated measles vaccine: characteristics and use. Rev Infect Dis. 1983 May-Jun;5(3):477–481. doi: 10.1093/clinids/5.3.477. [DOI] [PubMed] [Google Scholar]
- Markowitz L. E., Preblud S. R., Fine P. E., Orenstein W. A. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J. 1990 Feb;9(2):101–110. doi: 10.1097/00006454-199002000-00008. [DOI] [PubMed] [Google Scholar]
- Markowitz L. E., Preblud S. R., Orenstein W. A., Rovira E. Z., Adams N. C., Hawkins C. E., Hinman A. R. Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med. 1989 Jan 12;320(2):75–81. doi: 10.1056/NEJM198901123200202. [DOI] [PubMed] [Google Scholar]
- WATSON G. I. Protection after exposure to measles by attenuated vaccine without gamma-globulin. Br Med J. 1963 Mar 30;1(5334):860–861. doi: 10.1136/bmj.1.5334.860. [DOI] [PMC free article] [PubMed] [Google Scholar]